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Vibrio campbellii is a major pathogen in aquaculture. It is a causative agent of the
so-called “luminescent vibriosis,” a life-threatening condition caused by bioluminescent
Vibrio spp. that often involves mass mortality of farmed shrimps. The emergence of
multidrug resistant Vibrio strains raises a concern and poses a challenge for the treatment
of this infection in the coming years. Inhibition of bacterial cell-to-cell communication or
quorum sensing (QS) has been proposed as an alternative to antibiotic therapies. Aiming
to identify novel QS disruptors, the 9H-fluroen-9yl vinyl ether derivative SAM461 was
found to thwart V. campbellii bioluminescence, a QS-regulated phenotype. Phenotypic
and gene expression analyses revealed, however, that the mode of action of SAM461
was unrelated to QS inhibition. Further evaluation with purified Vibrio fischeri and
NanoLuc luciferases revealed enzymatic inhibition at micromolar concentrations. In silico
analysis by molecular docking suggested binding of SAM461 in the active site cavities of
both luciferase enzymes. Subsequent in vivo testing of SAM461 with gnotobiotic Artemia
franciscana nauplii demonstrated naupliar protection against V. campbellii infection at low
micromolar concentrations. Taken together, these findings suggest that suppression of
luciferase activity could constitute a novel paradigm in the development of alternative
anti-infective chemotherapies against luminescent vibriosis, and pave the ground for
the chemical synthesis and biological characterization of derivatives with promising
antimicrobial prospects.
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INTRODUCTION
Bacterial cell-to-cell communication or quorum sensing (QS) is
a population-density-dependent extracellular signaling process
that enables the coordination of collective behaviors in several
bacterial species. This intercellular communication system relies
on the synthesis, secretion and detection of signaling molecules
termed autoinducers (AIs), which enable bacteria to optimize
their metabolic resources and carry out tasks that are only
possible at high cellular densities. Thus, QS exerts a tight control
over bacterial gene expression, often involving hundreds of genes
(Wilder et al., 2011; Majerczyk et al., 2016; Ball et al., 2017).
Some of the QS-regulated physiological processes in diverse
bacterial models include biofilm formation, host colonization
and virulence factor production (Zhu and Mekalanos, 2003;
Bassler and Losick, 2006; Waters et al., 2008; Ruwandeepika
et al., 2011a; Bjelland et al., 2012). For this reason and given
that, in principle, signal interference would not impose a
selective pressure on bacterial populations, QS disruption has
been proposed as a more selective target in the development of
antibacterial therapies (LaSarre and Federle, 2013).
Vibrio campbellii is a marine bacterium whose
bioluminescence is controlled by a complex QS regulatory
system. Three hybrid sensor kinases, LuxN, LuxPQ, and CqsS
responding to three different AIs converge in a response
regulator, LuxO that controls the transcription of the mRNA
encoding the master regulator of the QS regulon, LuxR. Upon
DNA binding, LuxR enables the expression of hundreds of
genes including the luciferase structural operon luxCDABEGH,
where luxAB encode the two subunits of the bacterial luciferase
(Meighen, 1991; Waters and Bassler, 2006). LuxG and LuxH are
not essential for light production, though, and are not present in
other bacterial lux homologs (Waidmann et al., 2011). Because
of its QS-regulated light production and its well-characterized
QS system, V. campbellii has been widely employed as a model
biosensor to screen for QS inhibitors (Martín-Rodríguez and
Fernández, 2016).
V. campbellii is a pernicious pathogen in aquaculture, affecting
farm stocks of fish, shrimps and mollusks worldwide (Austin
and Zhang, 2006; Haldar et al., 2011; Wang et al., 2015).
Diseases caused by V. campbellii include skin ulcers, vasculitis,
gastrointestinal disorders and eye lesions in fish (Austin and
Zhang, 2006; Shen et al., 2017) and the so-called “luminescent
vibriosis” in crustaceans and mollusks, often involving mass
mortality and extensive economic loss (Travers et al., 2009;
Darshanee Ruwandeepika et al., 2012; Lio-Po, 2016). This disease
owes its name to the bioluminescence displayed by its causative
agents, primarily V. campbellii and V. harveyi. Mortality rates
between 60 and 80% have been reported in abalone (Haliotis
tuberculata), up to 85% in white shrimp (Litopenaeus vannamei)
and up to 100% in salmonids (Defoirdt et al., 2007a), with
global estimated costs for this disease exceeding $9 billion per
year (Bondad-Reantaso et al., 2005). The indiscriminate use
of antibiotics over decades has resulted in the emergence of
multidrug-resistant V. campbellii strains (Scarano et al., 2014).
The need for sustainable alternative therapies is even more
urgent taking into account the tight regulations and growing
public health concerns associated with the use of antibiotics in
aquaculture (Defoirdt et al., 2011).
Experimental characterization of novel drug candidates for
aquaculture requires representative and reliable animal models.
In this context, the Artemia franciscana naupliar gnotobiotic
model is well-established, with the nauplii being relatively easy
to rear under germ-free conditions and providing the additional
advantage of eliminating any indirect effects caused by host
microbiota, thereby allowing a direct cause-effect association
during drug candidate testing (Baruah et al., 2015). In an effort
to find QS antagonists from chemical libraries, SAM461 was
identified as a potent inhibitor of V. campbellii bioluminescence
with no inhibitory effect on bacterial growth at effective doses in
the low-micromolar range. Here we describe our characterization
of its mode of action and in vivo performance using axenically-
hatched A. franciscana nauplii.
MATERIALS AND METHODS
Strains and Growth Conditions
The V. campbellii strains used in this study are listed in
Table 1. Bacteria were recovered from cryopreserved stocks on
marine agar (Difco). Single colonies were used to start the
experiments as described below.When necessary, ampicillin (100
µg ml−1) and isopropyl-β-D-thiogalactoside (IPTG; 200µM)
were supplemented.
Synthesis of SAM461
(E)-Methyl 3-((9H-fluoren-9-yl)oxy)acrylate (SAM461) was
synthesized using 9-hydroxyfluorene (380mg, 2.00 mmol) as
TABLE 1 | Strains and primers used in this study.
Strains Genotype and relevant
characteristics
Source or references
Vibrio campbellii
ATCC-BAA 1116
(BB120)
Wild type strain. Bassler et al., 1994
Vibrio campbellii
JAF548 pAKlux1
Strain JAF548 (BB120 luxO
D47E linked to Kanr) carrying
plasmid pAKlux1 (Ampr), a
pBBR1MCS-4 derivative
containing the luxCDABE
operon from Photorhabdus
luminescens.
Luminescence independent of
quorum sensing.
Defoirdt et al., 2012
Primers Sequence Source or references
qVhluxR_F TCAATTGCAAAGAGACCTCG Defoirdt et al., 2007b
qVhluxR_R AGCAAACACTTCAAGAGCGA Defoirdt et al., 2007b
qVHluxA_F ATTTGCCGCAACTTCTTGGG This study
qVHluxA_R TGGTGTCTTTGTGGCCTTTC This study
qVHluxC_F AGATGCATTCGCCGCAAAAG This study
qVHluxC_R AACGTTGAAGTGGTCGCATG This study
qVhrpoA_F CGTAGCTGAAGGCAAAGATGA Defoirdt et al., 2007b
qVhrpoA_R AAGCTGGAACATAACCACGA Defoirdt et al., 2007b
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starting material. Methyl propiolate (1.3 equiv) was added
portionwise under Ar atmosphere (six portions, one portion
every 5min) to a solution of the alcohol (1 equiv) and DABCO
(0.1 equiv) in dry dichloromethane (0.4M). After thin-layer
chromatography (TLC) analysis revealed a complete reaction
(1 h approximately), the product was concentrated and
purified by flash chromatography (28 cm of height of silica gel,
n-hexane/Et2O 85/15) affording SAM461 (515mg, 97%) as a
yellowish solid consistent with reported data (Tejedor et al.,
2014). SAM461 molecular weight (MW) and octanol:water
partition coefficient (cLogP) were calculated with ChemBioDraw
Ultra 13.0.0.3015 (CambridgeSoft, PerkinElmer).
Spectroscopic data of SAM461: RF 0.38 (n-hexane/Et2O 80/20
two times); 1H-NMR (400 MHz, δ, CDCl3) 3.64 (s, 3H), 5.47
(d, J = 12.3Hz, 1H), 5.94 (s, 1H), 7.28–7.35 (m, 2H), 7.40–7.47
(m, 3H), 7.55 (d, J = 7.5Hz, 2H), 7.67 (d, J = 7.5Hz, 2H); 13C-
NMR (100 MHz, δ, CDCl3) 51.1 (q), 82.7 (d), 99.4 (d), 120.3 (d,
2C), 125.5 (d, 2C), 128.1 (d, 2C), 130.0 (d, 2C), 140.9 (s, 2C), 141.1
(s, 2 C), 160.8 (s), 168.0 (s); MS (EI) m/z (relative intensity) 266
(M)+ (1), 166 (30), 165 (100), 163 (11), 139 (5), 115 (3); HRMS
calcd for C17H14O3 (M)+ 266.0943, found 266.0942. 1H and
13C-NMR spectra (Figure S1) were recorded on Bruker Avance
instruments at room temperature, and data were processed using
Topspin software (version 2.1); chemical shifts (δ) are reported
in parts per million (ppm), and coupling constants (J) are quoted
in Hertz (Hz); 1H-NMR spectrum is referenced to the resonance
from residual CHCl3 at 7.250 ppm and multiplicity is expressed
by the abbreviations m (multiplet), s (singlet) and d (doublet);
13C-NMR spectrum is referenced to the central peak of the
signal from CDCl3 at 77.00 ppm, multiplicity was assigned from
DEPT135 and DEPT90 experiments and is expressed by the
abbreviations s (C), d (CH) and q (CH3). Mass spectra were
recorded with an AutoSpec Micromass spectrometer by using
electronic impact (EI-TOF 70 eV).
Growth Curves And Quorum Sensing
Assays With Vibrio campbellii
Quorum sensing inhibition assays were performed in
autoinducer bioassay (AB) medium (17.5 g l−1 NaCl, 12.3 g
l−1 MgSO4, 2.0 g l−1 casamino acids, 0.01M potassium
phosphate, 0.001M L-arginine, 1% v/v glycerol) as previously
described (Martín-Rodríguez and Fernández, 2016). Briefly,
diluted overnight cultures (1:100) were exposed to serial
dilutions of SAM461 in sealed, white, clear bottom 96-well plates
(Costar 3610). To keep solvent concentration to a minimum, a
highly concentrated stock solution of SAM461 in DMSO was
used (80mM). Control experiments involved non-treated cells
(untreated control) and cells supplemented with a volume of
DMSO equivalent to that of the highest treatment dose (solvent
control). Luminescence and optical density at 600 nm were
measured every 15min for 18 h in a multimode plate reader
(PerkinElmer EnSpire). Luminescence reads of treatments were
normalized with respect to that of the controls, and dose-
response curves were adjusted using a four-parameter non-linear
regression model as implemented in GraphPad Prism v5 (Prism
Software). Experiments were run in triplicate.
RNA Extraction, cDNA Synthesis And
qRT-PCR
Overnight V. campbellii BB120 cultures were diluted 1:100 in
AB medium with (8µM) and without SAM461. The untreated
control received a proportional amount of DMSO (0.01% v/v).
Three biological replicates were prepared per condition. Bacterial
cultures were incubated aerobically at 30◦C for 8 h before RNA
was isolated with the High Pure RNA Isolation Kit (Roche) as
recommended by the manufacturer. Residual genomic DNA was
removed after treatment with 5U RNAse-free DNAse (Promega).
Complementary DNA (cDNA) synthesis was performed with
the First Transcriptor cDNA synthesis kit (Roche) according
to the manufacturer’s instructions using 1 µg of total RNA.
Expression of luxR, luxA and luxC and rpoD was determined
using the primers listed in Table 1. Quantitative PCR reactions
were prepared with the SensiMix SYBR & Fluorescein Kit
(Bioline) in sealed optical 96-well plates using a Bio-Rad MyIQ
instrument. Gene expression for treated and untreated cells
was calculated with the qbase+ software (Biogazelle) and the
statistical significance of the differences was analyzed by a two-
tailed Student’s t-test. Significance was set at P = 0.05.
Enzymatic Assays With Vibrio fischeri And
NanoLuc Luciferases
Bacterial luciferase assays were conducted with commercial
Vibrio fischeri luciferase (VfLuc) (Sigma-Aldrich L8507), which
is a close analog of that of V. campbellii, as described previously
(Cruz et al., 2011). Briefly, 2 µl of substrate and cofactor solution
(final concentrations after addition of enzyme solution: 0.06%
BSA, 0.64mM decanal, 25µM FMN, 0.5mM NADH) were
dispensed inside the wells of a 1,536-well white/solid bottom
high base plate (Greiner 789175), to which either 25 or 50
nl of compound stock solution were added from a 384-well
acoustically compatible compound plate (Greiner 788876) using
an ATS-100 acoustic dispenser (EDC Biosystems; 250 µM-
122 nM, 12 point-titration with duplicates, DMSO, tartrazine
and pifithrin-α as controls). The mixture was incubated for
5min and then 2 µl of enzyme solution were added to each
well of the 1,536-well plate (final concentrations: 1.88 g ml−1
bacterial luciferase and FMN reductases, approximate protein
concentration of 0.75mg ml−1); enzyme buffer (100mM pH 7.0
sodium phosphate buffer) was used as control. After a 3-min
incubation period at room temperature in the dark, luminescence
was monitored for 180 s using a ViewLux system (PerkinElmer)
with the following settings: gain = high (23X); speed = high
(0.5 µs); binning = 6X, flatfield corrected using NanoLuc
(Promega) standard.
NanoLuc (NLuc) luciferase inhibition testing was performed
as described previously (Dranchak et al., 2013). Thus, 2 µl of
NLuc assay substrate (Nano-Glo luminescence assay, Promega)
(final concentrations: 300mM sodium ascorbate, 5mM sodium
chloride, 0.1% triton X-100, 20µM coelenterazine in 1X PBS,
pH 7.4) were dispensed into white solid-bottom 1,536 well plates
(Greiner Bio One) with a BioRAPTR FRD (Beckman Coulter).
Compounds were transferred to the plates in 25–50 nl by an
Echo acoustic dispenser (Labcyte) in the concentration range of
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244 nM to 250µMalong with DMSO and titrations of cilnidipine
positive control from top concentration of 125µM. NLuc
substrate reagent and compounds were incubated for 10min at
room temperature and one volume secreted NLuc medium was
added with a BioRAPTR FRD. NLuc enzyme luminescence was
measured using a ViewLux plate reader (PerkinElmer).
Docking of SAM461 to Vibrio campbellii
Luciferase and NanoLuc
Molecular docking was used to investigate the binding sites of
SAM461 to both the V. campbellii luciferase alpha chain (VcLuc)
and NLuc, whose crystal structures are available from the Protein
Data Bank (PDB). The potential binding areas (cavities) were
found using CavityPlus (Xu et al., 2018), which detects cavities
in the structure and informs about potential allosteric sites based
on motion correlation analyses. Structure coordinates for VcLuc
(PDB ID: 3FGC; Laskowski and Swindells, 2011) and NLuc
(PDB ID: 5IBO) were used, after the heteroatoms were removed
prior to docking. The 3D models of the ligands were created
using ChemDraw Professional (CambridgeSoft, PerkinElmer).
Docking experiments were performed using VINA (Trott and
Olson, 2010) via YASARA (Krieger and Vriend, 2014), and the
runs were clustered according to a root-mean-square-deviation
(RMSD) cut-off of 5 Å. A grid box was placed around the
residues forming the cavity of interest, localizing the docking
area. Interactions between protein and ligands were initially
analyzed using LigPlot+ (Laskowski and Swindells, 2011), and
the ligand-protein complex was further examined and imaged
with UCSF Chimera (Pettersen et al., 2004).
Hatching of Axenic Artemia franciscana
Nauplii
Approximately 60mg of A. franciscana cysts originating from
the Great Salt Lake, Utah, USA (EG Type, batch 21452, INVE
Aquaculture) were hydrated in 9ml of sterile artificial seawater
for 1 h. Sterile seawater was prepared by adding 3.5% of
Instant Ocean R© synthetic sea salt (Aquarium Systems) to 1 l
of distilled water and filter-sterilizing. The cysts were sterilized
and decapsulated by treatment with 330 µl NaOH (32%) and
5ml NaOCl (50%) under constant, 0.2-µm filtered aeration. The
reaction was stopped after 2min by addition of 5ml Na2S2O3
(1%) and aeration was discontinued. The decapsulated cysts
were washed, re-suspended in sterile seawater and incubated
for 28 h under constant illumination (27 µE m−2s−1). The
sterility of the hatched A. franciscana nauplii was verified by
adding hatching water (500 µl) to a tube containing marine
broth (Difco) as well as spread plating (100 µl) on marine agar
(Difco), followed by incubation at 28◦C for 5 days (Baruah
et al., 2011). Experiments started with non-sterile nauplii were
discarded.
Artemia franciscana Challenge Assays And
Lethality Tests
A survival dose-response relationship for SAM461 was
determined as described previously (Baruah et al., 2015).
Briefly, a group of 20 germ-free nauplii at developmental stage
II (in which their mouth is open to ingest food particles) was
transferred to sterile 40ml glass tubes containing 10ml of sterile
artificial seawater. Working 1mM solutions of SAM461 were
prepared in sterile seawater (10ml) from a stock solution of
the compounds in DMSO. The DMSO concentration in the
different experimental groups was adjusted as per the solvent
concentration in the highest dose group. Treatments were
supplemented with SAM461 (0.125–8µM) and challenged
with V. campbellii at 107 cells ml−1. A. franciscana survival
was scored after 2 days by counting the number of live
nauplii. As controls, the following groups were maintained:
untreated nauplii that were not challenged with V. campbellii
(negative control), untreated nauplii that were challenged withV.
campbellii (positive control), and nauplii treated with DMSO and
challenged with V. campbellii (DMSO control). Each experiment
was performed in five replicates. Prior to challenge assays,
the cytotoxic effect of SAM461 (2–32µM) was determined in
germ-free A. franciscana nauplii in the absence of V. campbellii,
otherwise as described above. Survival data were subjected to
one-way analysis of variances (ANOVA) followed by Dunnett’s
post-hoc analysis as implemented in GraphPad Prism v5 (Prism
Software, La Jolla, CA). Statistical significance was set at
P = 0.05.
RESULTS
SAM461 Inhibits Bacterial Luminescence
Independently of Quorum Sensing
During the screening of diversity-oriented chemical libraries,
compound SAM461 (Figure 1A) was identified as a
bioluminescence inhibitor using V. campbellii BB120 as a
bioreporter. SAM461 is a drug-like molecule fulfilling Lipinski’s
rule of 5 (Lipinski et al., 2001), a commonly used “rule of
thumb” to determine the druglikeliness of a molecule. Therefore,
SAM461 was synthesized in larger amounts to investigate its
mode of action. Hence, we analyzed its effect on V. campbellii
BB120 growth and bioluminescence in the concentration range
0.39–200µM. SAM461 was found to be toxic to V. campbellii
BB120 at concentrations >100µM (data not shown), therefore
these higher concentrations were excluded from further analysis.
Testing of serial 2-fold dilutions of SAM461 from 50 to 0.39µM
revealed dose-dependent luminescence quenching (Figure 1B).
The observed luminescence inhibition was not associated to
alteration of bacterial growth rates at these doses, with only a
slight growth delay being observed at the highest concentration
of 50µM (Figure 1B). To determine the potency of SAM461,
dose-response curves were prepared. The IC50 for luminescence
inhibition in V. campbellii BB120 was found to be 7.8µM
(Figure 1C). Taken together, these results indicate that SAM461
inhibits bacterial bioluminescence at non-toxic concentrations
in the low micromolar range.
We initially hypothesized that SAM461 could be a QS
inhibitor. Therefore, we performed the same experiment
described above in a V. campbellii mutant displaying
bioluminescence independently of QS. Thus, V. campbellii
JAF548 is a BB120 isogenic mutant harboring a point mutation
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FIGURE 1 | SAM461 inhibits Vibrio campbellii bioluminescence independently of quorum sensing. (A) Chemical structure and relevant chemical properties of
SAM461. (B) V. campbellii BB120 growth (left y axis) and luminescence curves (right y axis) in the presence of SAM461 (0.39–50µM), including solvent (DMSO) and
untreated controls. The arrow highlights the dose-dependent luminescence quenching induced by SAM461. (C) Dose-response curves for SAM461-induced
luminescence inhibition in V. campbellii BB120 (WT strain) and JAF548 pAKlux1 (constitutively luminescent mutant independent of QS). (D) Relative expression of
luxR, luxA, and luxC in the absence (control) and presence (8µM) of SAM461.
in the luxO allele that renders the cell constitutively non-
luminescent (Defoirdt et al., 2012). Bioluminescence had been
restored in this strain upon introduction of plasmid pAKlux1
harboring the luxCDABE operon from Photorhabdus luminescens
under the lac promoter (Table 1). Hence, luminescence
inhibition in this strain would indicate targets outside the QS
circuit. SAM461 inhibited light production in this reporter strain
similarly as in V. campbellii BB120 (IC50 = 3.6µM, Figure 1C),
thereby indicating the existence of targets beyond cell-to-cell
communication.
To confirm that QS inhibition does not contribute to
SAM461-induced luminescence quenching we determined the
transcript levels of luxR, encoding the QS master regulator,
as well as luxC and luxA, two of the QS-regulated genes in
the luxCDABEGH operon, in treated (8µM) and untreated
V. campbellii BB120 cultures. The expression of these three
genes was found to be not significantly different in treated
and untreated V. campbellii cells (Figure 1D). This confirms
unambiguously that SAM461 activity is independent of QS
disruption.
SAM461 Inhibits Luciferase Activity
We have shown that SAM461 displays potent bioluminescence
inhibition in V. campbellii at low micromolar doses in a QS-
independent fashion. We therefore reasoned that the potent
effect observed in live bacteria (Figure 2A) could be due to
inhibition of the bacterial luciferase enzyme. Using purified
V. fischeri luciferase (VfLuc), we measured enzyme activity in
the presence of serial dilutions of SAM461. Indeed, SAM461
inhibited VfLuc in vitro with an IC50 = 191.1µM, indicating
a moderately potent activity in comparison to other VfLuc
inhibitors, such as tatrazine and PFT-α used as controls (Kim
and Spiegel, 2013; Figure 2B). To determine the specificity of
SAM461, we further tested this compound against NLuc, which is
structurally and biochemically different to the bacterial luciferase
(Figure 2C). SAM461 was found to inhibit NLuc activity with an
IC50 = 149.5µM, a similar value to that determined for VfLuc.
Taken together, these findings suggest that SAM461 inhibits
luciferase activity non-selectively.
Molecular Docking
To gain an insight on the molecular interactions of SAM461
and its luciferase protein targets, an in silico analysis by
molecular docking was performed with the crystal structures of
V. campbellii luciferase (VcLuc) and NLuc.
Analysis of SAM461-VcLuc Interactions
Putative allosteric sites in VcLuc were detected by CavityPlus
based on the cavity containing the active site. Since the X-ray
structure of VcLuc was solved in complex with the substrate
FMNH2, docking of FMNH2 was used to test the reliability of
the docking results. For both SAM461 and FMNH, 400 docking
poses were generated in the putative allosteric sites and the
active site. To evaluate the docking results of SAM461 and
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FIGURE 2 | SAM461 interferes with bacterial luciferase activity. (A) Phenotypic evidence of potent bioluminescence inhibition caused by SAM461 (8µM) in Vibrio
campbellii BB120. (B) Half-maximal inhibitory concentration of SAM461 for Vibrio fischeri luciferase (VfLuc) and NanoLuc luciferase (NLuc). Tartrazine and PFT-α were
used as positive controls for VfLuc inhibition, and cilnidipine was used as positive control for NLuc inhibition. DMSO was used as solvent control. (C) Substrates,
cofactors and products involved in the redox processes catalyzed by the bacterial luciferase (V. campbellii, VcLuc) and NLuc resulting in light emission. Protein
structures were retrieved from the Protein Data Bank (PDB: 3FGC–VcLuc, and 5IBO–NLuc).
FMNH2, the binding energy (kcal mol−1) and calculated affinity
(CA; µM) of the docked ligands were considered. Docking of
SAM461 to the different cavities of VcLuc revealed a significantly
different binding energy and CA (over 15-fold) when docked
in the FMNH2 binding site compared to the potential allosteric
cavities (Table 2). The highest scoring pose in the first cluster
exhibited a binding energy of −8.7 kcal mol−1 and a CA of
0.36µM. However, the highest scoring pose in the second cluster
is hydrogen bonded, establishing an interaction of SAM461
with Arg107 and Gly108 (Figures 3A,B). Due to the apparent
flexibility of the acrylate chain, the hydrogen bond interactions
would likely stabilize this binding pose in the cavity.
Docking of FMNH2 to VcLuc yielded a similar pose as
that observed in the X-ray structure (Figure S2A). Because the
aliphatic chain in this molecule is also likely to be flexible,
differences in the chain orientation were observed. Despite
this apparent flexibility, both the docked and crystal resolved
molecule (Laskowski and Swindells, 2011) formed very similar
hydrogen bonds and residue contacts. They shared hydrogen
bonds with Glu43, Ala75, Arg107, Leu109, Glu175, Ser176 and
Thr179, andmultiple shared hydrophobic interactions with other
residues (Figures S2B,C). The hydrogen bond to Arg107 was
also observed for SAM461. Docking of FMNH2 displayed a
calculated binding energy of −9.1 kcal mol−1 and a CA of
0.21µM. Superposing the ligand-receptor complexes showed a
similar orientation of both SAM461 and FMNH2, with the rigid
aromatic rings against the hydrophobic cavity, and the flexible
region pointing toward the cavity opening (Figure 3C).
Analysis of SAM461-NLuc Interactions
NLuc does not have a confirmed substrate binding site, but
it is assumed that the active site is located in the central
TABLE 2 | Docking binding energy and calculated affinity of the highest scores in
the different cavities of Vibrio campbelli luciferase (VcLuc).
Ligand Cavity VcLuc Binding energy
(kcal mol−1)
Calculated
affinity (µM)
SAM461 FMNH2 binding site (hydrogen
bond)
−7.6 2.3
FMNH2 binding site (highest
score)
−8.7 0.36
Potential Allosteric site 1 −6.5 14.8
Potential Allosteric site 2 −7.0 6.6
Potential Allosteric site 3 −7.0 6.8
FMNH2 FMNH2 binding site −9.1 0.21
Cavity NLuc
SAM461 Potential Active Site −6.7 11.9
Potential Allosteric site −5.9 41.4
Furimazine Potential Active site −7.4 3.8
Potential Allosteric site −7.0 7.1
Potential allosteric sites were detected by CavityPlus.
cavity, since it should be able to accommodate the substrate
coelenterazine (Laskowski and Swindells, 2011). CavityPlus
detected one possible allosteric cavity based on this active site.
Furimazine was docked to both the active and potential allosteric
site to compare with the results of SAM461. In contrast to
VcLuc, the docked binding energy and CA for NLuc were not
as different between the two cavities, but the active site provided
a higher calculated affinity for both ligands (Table 2). The highest
scoring SAM461 pose in the active site has the fluorene rings
oriented toward the hydrophobic interior of the cavity, and the
acrylate chain turning outwards (Figure 3D). This pose allows
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hydrogen bonding with Leu45 and Asp46, and hydrophobic
contacts with 7 other residues (Figure 3E). The highest scoring
pose of furimazine in the same site did not form hydrogen bonds,
but 11 hydrophobic contacts, many of which are shared with
the SAM461 pose (Figure S2D). When investigating the areas
surrounding the ligand, the larger cavity housing the active site
may provide better solvent protection for both furimazine and
SAM461 (Figures S2E,F).
SAM461 Protects Artemia franciscana
From Vibrio Campbellii Infection
Light production is a major metabolic endeavor, and dark
mutants of pathogenic Vibrio are known to be less virulent than
their wild-type counterparts (Phuoc et al., 2009; Ruwandeepika
et al., 2011b). To determine the effect of SAM461 onV. campbellii
infectivity we used the gnotobiotic A. franciscana infection
model (Baruah et al., 2015). We first determined the toxicity of
SAM461 toward A. franciscana nauplii in the range 2–32µM.
The lowest dose of the compound exerting significant toxicity
was 16µM,whereas no toxicity was detected in the range 2–8µM
(Figure 4A).We next challenged germ-freeA. franciscana nauplii
withV. campbellii in the absence and presence of SAM461 at non-
toxic doses (0.125–8µM). SAM461 fully protected A. franciscana
from V. campbellii infection at concentrations as low as 2µM
(P < 0.001, Figure 4B). At this dose, A. franciscana survival was
increased 2-fold in comparison to untreated nauplii (Figure 4B),
thereby highlighting the therapeutic potential of this molecule.
DISCUSSION
Luminescent vibriosis caused by V. campbellii and close relatives
is a major disease with a remarkable economic impact. Growing
concerns related to the use of antibiotics in aquaculture
and the emergence of multidrug resistant bacterial pathogens
have motivated a global search of alternative therapeutic
and prophylactic options (Defoirdt et al., 2007a, 2011). In
this context, QS inhibitors have been proposed as promising
candidates (Bhardwaj et al., 2013; LaSarre and Federle, 2013;
Kim et al., 2018). Searching for potential QS inhibitors from
in-house chemical libraries (University of La Laguna, Spain),
compound SAM461 was identified as a hit during an initial
screening round involving testing of the chemicals against V.
campbellii BB120.
In this study we have delineated the mode of action of
SAM461. Given the known association between light production
and QS in V. campbellii, we initially envisioned that the
activity exhibited by SAM461 could be related to QS inhibition.
However, testing of SAM461 against a genetically-engineered,
constitutively luminescent V. campbellii mutant and subsequent
transcriptional analysis of luxR and QS-regulated genes revealed
a mode of action independent of QS disruption. This was not
completely surprising, though. V. campbellii produces three
types of QS signaling molecules: AI-1, an N-acyl homoserine
lactone; AI-2, a furanosyl borate diester; and CAI-1, a long-
chain amino ketone (Anetzberger et al., 2012). Even though
examples of QS inhibitors without chemical relatedness to the
natural autoinducers exist, most of the known QS disruptors
are chemical analogs of the native signal ligands (Galloway
et al., 2011; Kalia, 2013; Martín-Rodríguez et al., 2016), which
is not the case of SAM461. Nevertheless, with a half-maximal
inhibition value in the single-digit µM range and no toxicity
in the bacterial population as determined by growth inhibition
at effective doses, the activity of this molecule deserved further
characterization.
FIGURE 4 | SAM461 confers protection to Artemia franciscana nauplii against Vibrio campbellii BB120 at non-toxic concentrations. (A) Toxicity of SAM461 to
germ-free A. franciscana. Nauplii were exposed to SAM461 at the indicated doses. Un-exposed nauplii served as negative control. Nauplii exposed to only DMSO
served as solvent control. Survival was scored after 48 h of exposure. Data are presented as fold-change relative to the negative control, which has been normalized
to 1 (dotted line). Data represent the mean ± standard error of five replicates. Asterisks indicate significant differences relative to the negative control (***P < 0.001).
(B) Survival rate of A. franciscana nauplii during co-challenge with V. campbellii. SAM461 was added to the culture water at indicated concentrations. Simultaneously,
the nauplii were challenged with V. campbellii at 107 cfu ml−1 for 48 h. Control groups included untreated nauplii challenged with V. campbellii (positive control),
DMSO-treated nauplii challenged with V. campbellii (DMSO control) and non-challenged (uninfected) nauplii (negative control). Data are presented as fold-change
relative to the negative control, which has been normalized to 1 (dotted line). Values represent the mean ± standard error of five replicates. Asterisks indicate
significant differences with respect to the positive control (**P < 0.01; ***P < 0.001).
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FIGURE 3 | Docking poses of ligand/substrate and their calculated
interactions. (A) Docking pose of SAM461 (second highest scoring) in the
predicted active site pocket of VcLuc. The images show the hydrophobic
surface areas marked as magenta, and hydrophilic areas in cyan based on the
hydrophobicity scale of Kyte and Doolittle (57). (B) Interaction diagram of the
docked SAM461 molecule in the VcLuc active site. The interactions represent
the second docking cluster, displaying hydrogen bonds together with
hydrophobic contacts. The dotted green lines represent hydrogen bonds. Red
lines indicate hydrophobic interactions between protein residues and ligand
atoms. (C) Comparison of the X-ray structure of the FMNH-VcLuc complex
(green; PDB: 3FGC) and the docking pose of SAM461 (yellow) in the active
site pocket of VcLuc. The general poses of the molecules are similar, with the
rings turned toward the cavity interior and the flexible carbon chains forming
hydrogen bonds with residues closer to the cavity opening. (D) The docked
SAM461 ligand in the active site cavity of NLuc. (E) Interaction diagram of the
SAM461 ligand docked to the active site cavity of NLuc. The hydrogen bonds
(shown as dotted green lines) likely act to stabilize the flexible region of the
molecule.
We reasoned that the bioluminescence inhibition observed
in V. campbellii JAF548 pAKlux1 could be due to impaired
luciferase activity. Recall that in this dark mutant genetic
background the lux operon is ectopically expressed, thus
rendering the cells constitutively bright independently of the
cell population density. Indeed, SAM461 inhibited bacterial
luciferase activity in vitrowith an IC50 of 191.1µM. This IC50 was
2 orders of magnitude higher than that observed in live bacteria.
These differences between in vitro and in vivo activities are not
uncommon, and they have been reported for other bacterial
luciferase inhibitors in V. campbellii as well (Kim and Spiegel,
2013).
The biochemistry behind light production in Vibrio spp.
is complex (Kim and Spiegel, 2013). The bacterial luciferase
has three substrates: reduced flavin mononucleotide (FMNH2),
a long-chain fatty acid aldehyde (usually tetradecanal) and
molecular oxygen. FMNH2 is the product of the reduction of
FMN by NADPH, a reaction catalyzed by the enzyme NADPH
FMN oxidoreductase. FMNH2 is transferred to the bacterial
luciferase, where it is oxidized by molecular oxygen. This results
in the formation of hydroperoxide that reacts with a fatty
acid aldehyde produced by the fatty acid reductase complex.
The reaction of the aldehyde with hydroperoxide results in the
generation of an excited-state intermediate that emits blue-green
light and gives H2O and FMN as products. An overview of
this complex process has been presented in Figure 2C. Hence,
interference of SAM461 with the luciferase enzyme or any of
the proteins or metabolic pathways involved in substrate and
cofactor biosynthesis could lead to decreased light emission. The
biochemistry of the NLuc luciferase is different. This enzyme is
an engineered derivative of the naturally-occurring Oplophorus
gracilirostris luciferase and exhibits high substrate specificity.
Thus, NLuc catalyzes the oxidation of furimazine to produce
furimamide, carbon dioxide and an intense light output. Testing
of SAM461 against NLuc revealed similar performance as against
the bacterial luciferase, and therefore we deduced that SAM461 is
a non-selective luciferase inhibitor.
Although the docking experiments do not aim for the
validation of whether the SAM461 ligand binds in the active site
of its luciferase protein targets, our in silico results demonstrate
the chemical feasibility of such a scenario. Docking of SAM461
and FMNH2 showed similar theoretical binding energies and
calculated affinities when bound to the active site of VcLuc.
While these values might differ from the actual thermodynamic
parameters, the 15-fold decrease of CA determined for the active
site with respect to the allosteric site strongly suggest that both
ligands have a preferred theoretical binding toward the former.
The observation that the FMNH2 substrate displays similar
binding poses to the binding conformation of the flavin moiety in
the X-ray protein-substrate complex, but with differences in the
aliphatic chain conformation, supports the assumed flexibility.
Determining the binding of NLuc was more demanding since
the ligands showed similar affinity toward both the active
and allosteric binding sites, with furimazine having stronger
apparent affinity than SAM461 for both cavities. The larger cavity
harboring the active site could provide a better binding pocket
for both the native ligand furimazine and SAM461. The potential
allosteric site would possibly not offer enough protection against
the solvent. This together with the slightly preferred affinity
toward the active site could suggest SAM461 binds to the active
site of NLuc.
Luminescence has been reported to play a role in host
colonization and infectivity in both commensal and pathogenic
Vibrio spp. For example, luminescence genes have been shown
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to play an important role in the symbiotic colonization of the
luminescent organs of the squid host by V. fischeri (Visick
et al., 2000; Nyholm and McFall-Ngai, 2004; Chun et al., 2008).
In the fish pathogen V. salmonicida, luxA mutants showed
impaired infectivity and were outcompeted by the WT strain
in co-challenge tests in Atlantic salmons (Nelson et al., 2007).
In V. campbellii BB120 specifically, non-luminescent variants
have been found to be less virulent than their luminescent
counterparts in A. franciscana (Phuoc et al., 2009; Ruwandeepika
et al., 2011b). Consistent with these precedents, the luminescence
inhibitor SAM461 was found to protect A. franciscana from V.
campbellii infection at low micromolar doses. Previous studies
have found decreased virulence factor production and increased
susceptibility to host defense mechanisms in non-luminescent
variants of pathogenic Vibrio spp. (Szpilewska et al., 2003; Katsev
et al., 2004; Phuoc et al., 2009; Ruwandeepika et al., 2011b),
phenomena that could contribute to the observed performance
of SAM461 during in vivo infection experiments.
In conclusion, we have presented herein that targeting the
bacterial luciferase could constitute a novel paradigm in the
treatment of luminescent vibriosis. SAM461 is a small, drug-like
vinyl ether that supports diverse functionalities in its skeleton
(Tejedor et al., 2013; Zhu and Kirsch, 2013) thus streamlining
diverse-oriented synthesis and subsequent analyses of structure-
activity relationships based on this lead. The lack of chronic
toxicity of SAM461 at effective doses on the bacterial pathogen
as well as in the host results promising to prevent the emergence
of bacterial resistance and encourages its potential use as an
adjuvant chemotherapy.
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